Breast cancer patients benefit from treatments tailored specifically for their tumor

[News]

The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling...

More... (http://www.medicalnewstoday.com/releases/263620.php)